The worldwide incidence of melanoma has increased rapidly over the last 50 years. Melanoma is the most common cancer found in the young adult population, and its incidence is very high among geriatric populations. The incidence of melanoma varies by sex, and this factor is also associated with differences in the anatomical site melanoma. Adolescent and young adult women have a higher incidence than men. This may be, in part, due to the greater use of sunbeds, as well as intentional sun exposure among girls and, in general, risky behaviours in seeking to suntan, due to socially-determined aesthetic needs. Indeed, the World Health Organization declared that there is sufficient evidence to classify exposure to ultraviolet radiation (sunbed use and sun exposure) as carcinogenic to humans. Although pigmentation characteristics, such as skin colour, hair and eye colour, freckles and number of common and atypical naevi, do influence susceptibility to melanoma, recommendations regarding prevention should be directed to the entire population and should include avoiding sunbed, covering sun-exposed skin, wearing a hat and sunglasses. Sunscreen use should not be used to prolong intentional sun exposure. Primary prevention should be focused mainly on young adult women, while secondary prevention should be focused mainly on elderly men. In fact, after the age of 40 years, incidence rates reverse, and the incidence of melanoma among men is greater than among women. This is probably due to the fact that men are less likely than women to examine their own skin or present to a dermatologist for skin examination.
Eur J Cancer. 2005 Jan;41(1):45-60
[PMID:
15617990]
Eur J Cancer. 2005 Jan;41(1):28-44
[PMID:
15617989]
Aust N Z J Public Health. 2015 Oct;39(5):471-6
[PMID:
26437734]
Eur J Dermatol. 2014 Jan-Feb;24(1):35-40
[PMID:
24334101]
Prev Med. 2016 Oct;91:294-298
[PMID:
27565055]
Int J Cancer. 1998 Sep 25;78(1):8-12
[PMID:
9724086]
Int J Cancer. 2013 Jan 15;132(2):385-400
[PMID:
22532371]
N Engl J Med. 2005 Nov 17;353(20):2135-47
[PMID:
16291983]
BMJ. 2012 Oct 02;345:e5909
[PMID:
23033409]
Photochem Photobiol Sci. 2018 Dec 5;17(12):1853-1860
[PMID:
30113042]
J Clin Epidemiol. 2002 Nov;55(11):1075-81
[PMID:
12507670]
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):991-7
[PMID:
17507627]
Exp Dermatol. 2017 Jul;26(7):557-562
[PMID:
28266726]
Am Soc Clin Oncol Educ Book. 2018 May 23;38:88-100
[PMID:
30231343]
Int J Cancer. 1998 Oct 29;78(3):276-80
[PMID:
9766557]
Medicine (Baltimore). 2017 Apr;96(15):e6258
[PMID:
28403068]
J Natl Cancer Inst. 2003 Jun 4;95(11):806-12
[PMID:
12783935]
Am J Hum Genet. 2001 Oct;69(4):765-73
[PMID:
11500805]
J Am Acad Dermatol. 2015 Jun;72(6):1036-46.e2
[PMID:
25819940]
J Am Acad Dermatol. 2002 May;46(5):715-22
[PMID:
12004313]
Cancer Manag Res. 2018 May 14;10:1143-1154
[PMID:
29795986]
JAMA Dermatol. 2019 Jan 1;155(1):39-49
[PMID:
30477003]
Genet Epidemiol. 2015 Nov;39(7):509-17
[PMID:
26349638]
Ann Intern Med. 2003 Dec 16;139(12):966-78
[PMID:
14678916]
J Clin Oncol. 2016 Nov 20;34(33):3976-3983
[PMID:
27621396]
Soc Sci Med. 2000 May;50(10):1385-401
[PMID:
10741575]
Am J Epidemiol. 2017 Feb 1;185(3):147-156
[PMID:
28077359]
J Invest Dermatol. 2019 Mar;139(3):665-672
[PMID:
30367874]
J Clin Oncol. 2011 Jan 20;29(3):257-63
[PMID:
21135266]
Pediatrics. 1989 Aug;84(2):199-204
[PMID:
2748244]
J Clin Oncol. 2012 Jun 20;30(18):2240-7
[PMID:
22547594]
Arch Dermatol. 1996 Dec;132(12):1473-8
[PMID:
8961877]
Cancer Res. 1988 Sep 1;48(17):5036-41
[PMID:
3409232]
JAMA Dermatol. 2015 Sep;151(9):982-90
[PMID:
26039788]
Eur J Cancer. 2009 Nov;45(17):3054-63
[PMID:
19545997]
J Eur Acad Dermatol Venereol. 2019 Mar;33 Suppl 2:76-88
[PMID:
30811689]
Pigment Cell Melanoma Res. 2008 Oct;21(5):559-64
[PMID:
18702635]
BMC Med Res Methodol. 2012 Aug 03;12:116
[PMID:
22862891]
J Natl Cancer Inst. 2003 Dec 17;95(24):1878-90
[PMID:
14679157]
Anticancer Res. 2018 Feb;38(2):1187-1199
[PMID:
29374757]
Lancet. 2004 Feb 28;363(9410):728-30
[PMID:
15005091]
J Natl Cancer Inst. 2014 Sep 13;106(9):
[PMID:
25217772]
Cancer. 2000 Jul 15;89(2):342-7
[PMID:
10918164]
Am J Epidemiol. 2010 Oct 1;172(7):762-7
[PMID:
20813801]
Science. 2006 Jul 28;313(5786):521-2
[PMID:
16809487]
Arch Dis Child. 2006 Feb;91(2):131-8
[PMID:
16326797]
PLoS Med. 2014 Jun 10;11(6):e1001659
[PMID:
24915186]
Int J Cancer. 1998 Sep 11;77(6):843-8
[PMID:
9714052]
Curr Opin Oncol. 2019 Mar;31(2):65-71
[PMID:
30676536]
Melanoma Res. 2000 Oct;10(5):491-8
[PMID:
11095411]
Lancet. 1994 Dec 3;344(8936):1529-32
[PMID:
7983952]
JAMA Dermatol. 2016 Mar;152(3):268-75
[PMID:
26818409]
Cancer Causes Control. 2011 Jul;22(7):1067-71
[PMID:
21637987]
Anticancer Res. 2018 Feb;38(2):1111-1120
[PMID:
29374748]
Lancet. 1999 Aug 28;354(9180):723-9
[PMID:
10475183]
J Invest Dermatol. 2002 May;118(5):825-9
[PMID:
11982760]
J Am Acad Dermatol. 2018 Dec;79(6):1101-1108
[PMID:
30009864]
J Am Acad Dermatol. 2005 Jan;52(1):40-7
[PMID:
15627079]
J Am Acad Dermatol. 2019 May;80(5):1284-1291
[PMID:
30639880]
Eur J Cancer. 2005 Sep;41(14):2040-59
[PMID:
16125929]
Int J Cancer. 2015 Feb 1;136(3):618-31
[PMID:
24917043]
Health Policy. 2009 Mar;89(3):303-11
[PMID:
18760857]
J Photochem Photobiol B. 2001 Oct;63(1-3):8-18
[PMID:
11684447]
Medicine (Baltimore). 2016 Mar;95(11):e3034
[PMID:
26986121]
Br J Dermatol. 2013 Aug;169(2):351-7
[PMID:
23601037]
Eur J Dermatol. 2015 Jan-Feb;25(1):45-51
[PMID:
25547029]
Eur J Cancer. 2010 Feb;46(3):566-72
[PMID:
19815405]
J Am Acad Dermatol. 1996 Jun;34(6):962-70
[PMID:
8647989]
BMJ. 2012 Jul 24;345:e4757
[PMID:
22833605]
Cancer Causes Control. 1992 Nov;3(6):513-6
[PMID:
1420853]
JAMA. 2000 Jun 14;283(22):2955-60
[PMID:
10865273]
Acta Oncol. 1990;29(7):833-54
[PMID:
2261197]
J Natl Cancer Inst. 1983 Oct;71(4):651-6
[PMID:
6578359]
J Natl Cancer Inst. 1984 Jul;73(1):75-82
[PMID:
6588237]
Prev Med. 2019 May;122:81-90
[PMID:
31078176]
JAMA Dermatol. 2014 Apr;150(4):390-400
[PMID:
24477278]
Cancer Lett. 2005 Dec 18;230(2):153-86
[PMID:
16297704]
